Akari Therapeutics Plc

(AKTX) Trade

By |

Profile

Akari Therapeutics PLC is a biopharmaceutical company in clinical stage. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system.

Contact Information

Website: www.akaritx.com
Email: info@celsustx.com
Main Phone: +44 2080040270
Address: 75/76 Wimpole Street
Address 2: 8th Floor
State: NY
City / Town: London
Country: GBR
Postal Code: W1G 9RT

Issuer Information

Exchange: NSC
CEO: Gur-Arye Yehuda Roshwalb
Employees: 15
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 2.09 $ -0.03 (-1.42%)
Last Price 2.09 Change $ -0.03 Change % -1.42 Tick N/A
Bid 1.98 Bid Size 500.00 Ask 2.39 Ask Size 1,000.00
Open 2.10 High 2.12 Low 1.96 Prev Close 2.12
Last Trade Volume 58,001 52 Wk Hi 11.95 52 Wk Low 1.70
Market Cap 31.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 15,256,933.00 EPS (TTM) -3.03 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 8 8 8 8
Low Target Price Estimate 2.5 2.5 2.5 2.5
Mean Target Price Estimate 5.25 5.25 5.25 5.25
Standard Deviation 3.89 3.89 3.89 3.89
Date of Most Recent Estimate 03/29/18 03/29/18 03/29/18 03/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 2 2 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 1.67 1.67 2